If you have been reading about incretin and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-10-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Development of tirzepatide took place under a research program that sought to test whether simultaneous engagement of two incretin receptors would produce greater metabolic effects than single-receptor agonism. Clinical trials were organized into the SURPASS series for type 2 diabetes and the SURMOUNT series for obesity and weight management. Regulatory clearance for type 2 diabetes came in 2022 in the United States, followed by approval for chronic weight management in 2023. The trial programs reported reductions in glycated hemoglobin and body weight relative to comparators, though long-term cardiovascular and durability data continue to accumulate.
The peptide backbone contains 39 amino acids and includes alpha-aminoisobutyric acid residues, which are not among the standard proteinogenic set. A C20 fatty diacid moiety is attached through a linker, allowing the compound to bind serum albumin and extend its circulation time. This albumin binding is the main reason the molecule supports once-weekly administration rather than more frequent dosing. The measured molecular mass is approximately 4,813 daltons, placing it firmly in the peptide rather than small-molecule class.
Tirzepatide is a synthetic peptide that activates both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual agonist profile distinguishes it from earlier incretin-based compounds that act on a single receptor. The molecule was engineered from the native GIP sequence and carries several non-natural residues that slow enzymatic breakdown. Researchers designed it to combine the insulinotropic effects of GIP signaling with the appetite and gastric-emptying effects associated with GLP-1 activation.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Modified synthetic peptide | 39-residue backbone with non-natural residues |
| Receptor targets | GIP and GLP-1 | Dual incretin receptor agonist |
| Approximate molecular mass | 4,813 Da | Calculated from the peptide sequence |
| Administration route | Subcutaneous injection | Weekly schedule in approved products |
| Albumin binding | Present | Mediated by a C20 fatty diacid side chain |
Regulatory and quality discussions place the peptide within established guidance for synthetic peptides and biologics. Forced degradation studies, in which samples are exposed to heat, acid, base, peroxide, and light, identify likely degradation products and validate the selectivity of analytical methods. Reference standards allow comparison across laboratories and production batches. Purity specifications reported in the literature usually combine chromatographic purity with mass confirmation. Which impurity thresholds are meaningful for long-term behavior is still debated, and no single universal specification has been adopted across all jurisdictions.
Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.
Cold-chain handling is standard for formulated product, with dry powder stored frozen and ready-to-use solutions refrigerated. Light exposure is minimized because photodegradation of certain amino acid side chains is possible. Shipping and temperature-excursion studies are used to establish whether short deviations affect quality attributes. Documentation supplied with research material usually includes a certificate of analysis listing purity, identity confirmation, and water or residual solvent content. Users are expected to confirm that material meets the stated specification before use.
Identity and purity of tirzepatide are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Because the molecule carries several modifications, gradient conditions are adjusted to resolve the intact peptide from deamidation and oxidation products. Enzymatic digestion followed by peptide mapping confirms the primary sequence and locates specific modifications. Quantitation in biological matrices typically uses liquid chromatography with tandem mass spectrometry after solid-phase extraction. Immunoassays are used less often, since antibody cross-reactivity with closely related peptides can bias results.
The peptide shares degradation routes common to modified peptides: deamidation of asparagine and glutamine residues, oxidation of methionine, and backbone hydrolysis under extreme pH. Lyophilized material is generally more stable than a solution, and residual water content directly affects the rate of hydrolysis. In liquid form, aggregation and visible particles can appear after agitation or repeated freeze-thaw cycles. Stability studies therefore track monomer content, aggregate content, and potency over months under defined temperature and humidity.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Peptide-based pharmaceutical products such as tirzepatide require controlled temperature management to preserve structural integrity. Manufacturer labeling generally specifies refrigeration at 2 to 8 degrees Celsius before first use, with protection from light and freezing. Exposure to repeated temperature cycling can promote aggregation or deamidation, which alters the analytical profile even when the visible solution appears unchanged. Once a product is in use, the permitted storage window and temperature range are defined by the specific labeled presentation rather than by general peptide rules.
Identity and purity assessment of tirzepatide relies primarily on reversed-phase high-performance liquid chromatography coupled with ultraviolet detection. Mass spectrometry, often in electrospray ionization mode, confirms the molecular mass and detects sequence-related impurities. Peptide mapping after enzymatic digestion provides residue-level confirmation of the backbone. Each method addresses a different question: chromatography for purity and related substances, mass measurement for identity, and mapping for sequence fidelity. No single technique covers all three.
University of Port Harcourt Teaching Hospital was established in April 1980 and was officially commissioned by the federal government in 1985, it is a major tertiary-care teaching and research facility in Rivers State. It is as a result of the desire of the Federal Government to provide excellent medical services, manpower training, and research in all the geopolitical zones of the country. The mandate of the Hospital was derived from Decree 10 of 1985, University Teaching Hospitals (reconstitution of Board etc.) Decree. The current chief medical director is Professor Henry Arinze Anthony Ugboma. When it started out, there were 60 beds mainly in use. After relocating to its permanent site in 2006, the hospital's capacity was expanded to 500 beds and more. University of Port Harcourt Teaching Hospital is managed through a three-tier managerial system consisting - the Board of Management, Hospital Management Committee (HMC) and the Departments. Nearly 200,000 patients are seen annually in both outpatient and inpatient settings, as well as over 3000 surgical operations a year. Average bed occupancy rate in 12 months has risen above 80%. Besides offering medical services, the hospital tends to provide clinical education and training to students, nurses, and other healthcare professionals. Over the years, many research activities and results from its organized units have appeared on several major national and international medical and scientific journals.
Sulfate uptake occurs in roots. The maximal sulfate uptake rate is generally already reached at sulfate levels of 0.1 mM and lower. The uptake of sulfate by the roots and its transport to the shoot appears to be one of the primary regulatory sites of sulfur assimilation. Sulfate is actively taken up across the plasma membrane of the root cells, subsequently loaded into the xylem vessels and transported to the shoot by the transpiration stream. The uptake and transport of sulfate is ATP-dependent. Sulfate is reduced in the chloroplasts. Sulfate in plant tissue is predominantly present in the vacuole, since the concentration of sulfate in the cytoplasm is kept rather constant. Distinct sulfate transporter proteins mediate the uptake, transport and subcellular distribution of sulfate. The sulfate transporters gene family has been classified in up to 5 different groups according to their cellular and sub-cellular gene expression, and possible functioning. Each group of transporter proteins may be expressed exclusively in the roots or shoots of the plant, or both.
== See also == Carboxypeptidase E Carboxypeptidase A Enzyme category EC number 3.4 Thrombin-activatable fibrinolysis inhibitor aka plasma carboxypeptidase B2 Bacterial transpeptidase, an alanine carboxypeptidase Bradykinin is broken down among other enzymes by carboxypeptidase N DD-Ala carboxypeptidase is a penicillin-binding protein Phenylalanine might inhibit carboxypeptidase A Martha L. Ludwig
=== Economics === Economists have modeled the circumstances under which slavery (and variants such as serfdom) appear and disappear. One theoretical model is that slavery becomes more desirable for landowners where land is abundant, but labour is scarce, such that rent is depressed and paid workers can demand high wages. If the opposite holds true, then it is more costly for landowners to guard the slaves than to employ paid workers who can demand only low wages because of the degree of competition. Thus, first slavery and then serfdom gradually decreased in Europe as the population grew. They were reintroduced in the Americas and in Russia as large areas of land with few inhabitants became available. Slavery is more common when the tasks are relatively simple and thus easy to supervise, such as large-scale monocrops such as sugarcane and cotton, in which output depended on economies of scale. This enables systems of labour, such as the gang system in the United States, to become prominent on large plantations where field hands toiled with factory-like precision. Then, each work gang was based on an internal division of labour that assigned every member of the gang to a task and made each worker's performance dependent on the actions of the others. The slaves chopped out the weeds that surrounded the cotton plants as well as excess sprouts. Plow gangs followed behind, stirring the soil near the plants and tossing it back around the plants. Thus, the gang system worked like an assembly line.
== Use in humidity control == There is net evaporation from a solution with a water activity greater than the relative humidity of its surroundings. There is net absorption of water by a solution with a water activity less than the relative humidity of its surroundings. Therefore, in an enclosed space, an aqueous solution can be used to regulate humidity.
Sources: en.wikipedia.org
== Business career == Newsom and a group of investors created the company PlumpJack Associates L.P. on May 14, 1991. The group started the PlumpJack Winery in 1992 with the financial help of his family friend Gordon Getty. PlumpJack was the name of an opera written by Getty, who invested in 10 of Newsom's 11 businesses. Getty told the San Francisco Chronicle that he treated Newsom like a son and invested in his first business venture because of that relationship. According to Getty, later business investments were because of "the success of the first". One of Newsom's early interactions with government occurred when Newsom resisted the San Francisco Department of Public Health's requirement to install a sink at his PlumpJack wine store. The Health Department argued that wine was a food and required the store to install a $2,700 sink in the carpeted wine shop on the grounds that the shop needed the sink for a mop. When Newsom was later appointed supervisor, he told the San Francisco Examiner: "That's the kind of bureaucratic malaise I'm going to be working through." The business grew to an enterprise with more than 700 employees. The PlumpJack Cafe Partners L.P. opened the PlumpJack Café, also on Fillmore Street, in 1993. Between 1993 and 2000, Newsom and his investors opened several other businesses that included the PlumpJack Squaw Valley Inn with a PlumpJack Café (1994), a winery in Napa Valley (1995), the Balboa Café Bar and Grill (1995), the PlumpJack Development Fund L.P.
==== Aquaporin ==== The currently known aquaporins cluster loosely together as do the known glycerol facilitators. MIP family proteins are believed to form aqueous pores that selectively allow passive transport of their solute(s) across the membrane with minimal apparent recognition. Aquaporins selectively transport glycerol as well as water while glycerol facilitators selectively transport glycerol but not water. Some aquaporins can transport NH3 and CO2. Glycerol facilitators function as solute nonspecific channels, and may transport glycerol, dihydroxyacetone, propanediol, urea and other small neutral molecules in physiologically important processes. Some members of the family, including the yeast Fps1 protein (TC# 1.A.8.5.1) and tobacco NtTIPa (TC# 1.A.8.10.2) may transport both water and small solutes.
=== Insects and fish === It is attractive to males of various species of orchid bees, which apparently gather the chemical to synthesize pheromones; it is commonly used as bait to attract and collect these bees for study. It also attracts female cucumber beetles. Eugenol and isoeugenol, which both are floral volatile scent compounds, are catalyzed by a single type of enzyme in the genus Gymnadenia and the gene encoding for this enzyme is the first functionally characterized gene in these species. Eugenol is an ingredient in some insecticides. Clove oil is common as an anesthetic for use on aquarium fish as well as on wild fish when sampled for research and management purposes. Where readily available, it presents a humane method to euthanize sick and diseased fish either by direct overdose or to induce sleep before an overdose of eugenol.
For services to People with Autism and their Families in Oxfordshire. Elizabeth Craig Ovens. Director, McCaskies Butchers. For services to Retail and to the Economy in Scotland. Alfred Oluwafemi Oyekoya. Director, Black Asian Minority Ethnic Mental Health Support. For services to Minority Ethnic Communities in Wales. Caroline Rebecca Paige. For services to Armed Forces Personnel and Veterans. The Reverend Canon Dr. Crispin Alexander Pailing. Member, Merseyside Resilience Forum and Safety Advisory Group. For services to the community in Liverpool, Merseyside. Blair Parham. Director of Music and Principal Conductor, Scottish Fiddle Orchestra. For services to Scottish Music. Satish Manilal Parmar. Senior Policy Adviser, Department for Work and Pensions. For Public Service. Carys Parry. Voluntary Party Manager, Conservative Party. For Political Service. Imran Adam Patel. For services to the community in Blackburn, Lancashire. Wolodymyr Pawluk. Chair, London Branch, Association of Ukrainians in Great Britain and Member, National Executive Committee, Ukrainian Youth Association. For services to the Ukrainian Community. Ewan Benjamin Payne. Team UK Gold Medal Winner, WorldSkills UK. For services to Further Education. Catherine Penny. For services to Plant Heritage and to the community in North Preston, Lancashire. Professor Yvonne Perrie. Professor of Drug Delivery and Head, Institute for Pharmacy and Biomedical Sciences. For services to Pharmaceutical Innovation and Regulation. Timothy Foster Pick.
Therefore, a drug given by the intravenous route will have an absolute bioavailability of 100% (f = 1), whereas drugs given by other routes usually have an absolute bioavailability of less than one. If we compare the two different dosage forms having same active ingredients and compare the two drug bioavailability is called comparative bioavailability. Although knowing the true extent of systemic absorption (referred to as absolute bioavailability) is clearly useful, in practice it is not determined as frequently as one may think. The reason for this is that its assessment requires an intravenous reference; that is, a route of administration that guarantees all of the administered drug reaches systemic circulation. Such studies come at considerable cost, not least of which is the necessity to conduct preclinical toxicity tests to ensure adequate safety, as well as potential problems due to solubility limitations. These limitations may be overcome, however, by administering a very low dose (typically a few micrograms) of an isotopically labelled drug concomitantly with a therapeutic non-isotopically labelled oral dose (the isotopically labelled intravenous dose is sufficiently low so as not to perturb the systemic drug concentrations achieved from the non-labelled oral dose). The intravenous and oral concentrations can then be deconvoluted by virtue of their different isotopic constitution, and can thus be used to determine the oral and intravenous pharmacokinetics from the same dose administration.
Sources: en.wikipedia.org
Smoking, involves burning and inhaling cannabinoids ("smoke") from small pipes, bongs (portable versions of hookahs with a water chamber), paper-wrapped joints, tobacco-leaf-wrapped blunts, or the like. Vaporizing, heating various forms of cannabis to 165–190 °C (329–374 °F), causing the active ingredients to form vapor without combustion of the plant material (the boiling point of THC is 157 °C (315 °F) at atmospheric pressure). Edibles, adding cannabis as an ingredient to a wide variety of foods, including butter and baked goods. In India it is commonly consumed as the beverage bhang. Cannabis tea, prepared with attention to the lipophilic quality of THC, which is only slightly water-soluble (2.8 mg per liter), often involving cannabis in a saturated fat. Tincture of cannabis, sometimes known as green dragon, is an alcoholic cannabis concentrate. Capsules, typically containing cannabis oil, and other dietary supplement products, for which some 220 were approved in Canada in 2018.
=== Human Diseases and Gene Mutations === Greenspan has conducted various research projects directly on the molecular bases of human diseases. A collaborative study with a group at Jefferson Medical College showed mutations in the COL7A1 gene, for type VII collagen, to be the basis of the disabling and fatal skin disease dystrophic epidermolysis bullosa These studies also led to elucidation of the complete intron-exon structure of COL7A1 which at the time had more exons than any previously described gene. His lab was the first to clone and characterize the α1 chain of type V collagen and was also key in the first demonstration that mutations in a type V collagen gene can cause the heritable connective tissue disorder classic Ehers-Danlos syndrome. Accompanying and following these studies, the Greenspan lab has performed studies on collagen V genes and on the biosynthesis of type V collagen and on the molecular mechanisms whereby mutations in type V collagen result in defects in mammalian tissues. Their studies have also shown autoimmunity against type V collagen to be involved in organ transplant rejection and atherosclerosis, and that induction of immune tolerance to type V collagen can help ameliorate atherosclerosis. The Greenspan lab was also the first to clone and characterize the α3 chain of type V collagen and showed the α3(V) chain to be important to the functioning of certain highly specialized cell types and to be important to tumor growth and survival times in breast cancer.
== Taxonomy == Carl Linnaeus described the species in 1771, the specific epithet biloba derived from the Latin bis, "twice" and loba, "lobed", referring to the shape of the leaves. Two names for the species recognise the botanist Richard Salisbury, a placement by Nelson as Pterophyllus salisburiensis and the earlier Salisburia adiantifolia proposed by James Edward Smith. The epithet of the latter may have been intended to denote a characteristic resembling Adiantum, the genus of maidenhair ferns. The generic name Ginkgo can be traced to recordings done by Engelbert Kaempfer, the first Westerner to investigate the species in 1690 in Nagasaki, for the Amoenitates Exoticae (1712): it is regarded as a mistranscription of Japanese 銀杏 ginkyō ([ɡiŋkʲoː]). Taking his spelling of other Japanese words containing the syllable [kʲoː] (present romanization: kyō) into account, an expected transcription would have been "ginkio" or "ginkjo". Thus, his curious "–kgo" spelling has long been considered to be an error Kaempfer made in his notes, but Nagata et al. showed that it was the spelling of his interpreter, Genemon Imamura, who spoke the local Nagasaki dialect. Linnaeus adopted the ginkgo spelling based on Kaempfer's compilation of Japanese flora in Amoenitates while writing Mantissa plantarum II (Amoenitates Exoticae, p. 811) thus becoming the tree's generic name. Kaempfer's drawing can be found in Hori's article.
=== Mechanism of action === Reslizumab is an interleukin IL-5 antagonist monoclonal antibody. IL-5 is the major cytokine responsible for the growth and differentiation, recruitment, activation, and survival of eosinophils. Eosinophils play a role in the mediation of inflammation in the airways. Eosinophilic asthma is a phenotype of asthma that is characterized by the higher than normal presence of eosinophils in the lung and sputum. It has been shown that the numbers of eosinophils in the blood and bronchial fluid can correlate with asthma severity. Reslizumab binds to IL-5 with a dissociation constant of 81 pM and inhibiting IL-5 signaling, which reduces the production and survival of eosinophils. However, the mechanism of reslizumab action in asthma has not been definitively established.
On March 15, OSFI took permanent control of the bank and announced it would restructure SVB Canada to a new bridge bank to be created by the FDIC, after the regulator was unable to find a buyer. An initial auction of Silicon Valley Bank assets on March 12 attracted a single bid that was not from a bank, after PNC Financial Services and RBC Bank backed away from making offers. Bank of America, JPMorgan Chase, and Goldman Sachs all declined to make offers. The FDIC canceled the auction, scheduling a second to attract bids from major banks, after the systemic risk exception was granted. Mayopoulos urged venture capitalists and startups to keep their deposits in the bridge bank, apparently to improve its financial condition, and suggested that customers return some of the deposits they had recently pulled out of the bank as part of a diversification strategy. A group of venture capitalists called for depositors to keep at least half of their capital in the bank. The seizure of Silicon Valley Bank's assets severely disrupted SVB Financial Group's operations. The holding company was locked out of its Santa Clara headquarters, which were shared with the bank, forcing it to move its headquarters to its New York City offices. The holding company, bridge bank, and FDIC are discussing how to reorganize payroll systems. All of SVB Financial Group's employees have been on the payroll of Silicon Valley Bank, not SVB Financial Group, while the parent company has been providing employee benefits to all Silicon Valley Bank employees.
Sources: en.wikipedia.org
It binds and activates both the GIP and GLP-1 receptors, making it a dual incretin receptor agonist. Single-receptor GLP-1 agonists act on one target only. The dual profile is the defining pharmacological feature of the molecule.
A fatty diacid side chain promotes reversible binding to serum albumin. This association slows renal clearance and protects the peptide from rapid enzymatic degradation. The result is a prolonged circulation time that supports weekly administration.
The first regulatory approval, for type 2 diabetes, was granted in the United States in 2022. An additional approval for chronic weight management followed in 2023. Availability and approved indications vary by country and are set by each national regulator.
It activates both GIP and GLP-1 receptors. This dual action differentiates it from selective GLP-1 agonists.